An independent read on agri-food biomanufacturing — market data, the four themes we track, the technology behind smart proteins, and our latest white paper. Figures are dated and cited; where sources conflict, we say so.
An independent read on agri-food biomanufacturing, compiled from public industry sources. Estimates differ between sources, so figures here are indicative and dated — read them as direction, not precision.
Market size, the plant-based plateau, where 2024 investment landed, and the vertical-farming adjacency.
The broad alternative-protein market keeps compounding at a high-single-digit rate (≈8–9% CAGR), even as its sub-sectors move at very different speeds.
After years of rapid growth, plant-based retail has largely flattened — global sales up only slightly, and US dollar sales down ≈ 4% in 2024.
In 2025, total funding fell ~20% to $881M — below $1B for the first time since 2018. Plant-based led on headline value, but only because of a single $100M Beyond Meat debt round; fermentation fell ~43% and cultivated ~48%. Fermentation then took $121M of the $162M raised in Q1 2026.
Controlled-environment and vertical farming remain a fast-growing adjacency, though energy costs and unit economics still gate profitability.
A large, maturing market beside a fast-emerging one — with illustrative scenarios to 2030.
Europe is among the world's largest and most mature alternative-protein markets — roughly US$5.8B in 2023 (≈€5.4B across six major markets), now growing in the mid-single digits and flat-to-modest as of 2025–26. India's market is far smaller today (≈US$0.8B, ~5% of the global total) but sits much earlier on its curve: broad alternative-protein revenue is projected to reach ≈US$1.5B by 2030 (≈9% CAGR), while the narrower "smart protein" segment is projected to scale from ≈US$42M to US$1.5B–$4.2B by 2030 on policy tailwinds (DBT/BIRAC, the BioE3 policy) and a deep manufacturing and STEM base. With ≈ 90% of inputs still imported, India's largest gap — localized biomanufacturing — is also its clearest opportunity.
Figures are drawn from third-party market-research and industry reports and are provided for general analysis only. They are not forecasts, endorsements, or investment advice.
A closer read on the forces shaping agri-food biomanufacturing — the economics, the localization opportunity in India, where demand actually sits, and how capital and policy are moving.
Alternative proteins scale only as they close the gap on price. Plant-based meat still sells at a clear premium — on average roughly twice the price of conventional beef, and more versus pork and chicken — and about a fifth of consumers name cost as the reason they don’t buy. The route to parity runs through cheaper feedstocks, food-grade inputs, and sheer scale, where every doubling of capacity tends to cut unit cost by 20–30%.
India is among the world’s largest pulse producers, yet imports the large majority of its alternative-protein raw material and lacks domestic protein-fractionation capacity. Localizing feedstocks — pulses, soy, pea, chickpea, millets — and pooling capital-heavy fermentation infrastructure is where cost, supply-chain resilience, and jobs converge. This is the core of India’s national biomanufacturing push.
In Europe, plant-based milk and drinks lead (about 41% of category sales), with meat second; household penetration keeps rising and flexitarians now make up roughly a third of consumers. India’s market is younger but broad — hundreds of products and a fast-growing food-service presence — with taste, price, and perceived ‘naturalness’ the main barriers to repeat purchase.
Global investment cooled to $881M in 2025 — the first sub-$1B year since 2018. Plant-based led on headline value ($450M, flattered by one $100M debt round) while fermentation fell ~43% to $357M; fermentation then took $121M of the $162M raised in Q1 2026 as the field tilts toward B2B ingredients rather than finished products. Policy is increasingly decisive: India’s BioE3 policy names smart proteins a priority theme, backed by DBT and BIRAC funding, while regulatory pathways — FSSAI in India, and approvals already granted in Singapore and the US — continue to mature.
Smart proteins are made mainly by precision fermentation — engineered microbes brewing a target protein — and by cell cultivation. Two engineering paradigms are racing to make them cheap enough to matter, and increasingly merging.
Strength: works without full mechanistic insight — proven for enzymes and production strains.
Strength: narrows the search and cuts wet-lab cycles — reaching designs screening would miss.
The two paradigms are converging into AI-native, ‘self-driving’ biofoundries that close the design–build–test–learn loop with robotics — and India is explicitly building them. The decisive levers are moving out of the lab: toward scale-up capacity, cheaper food-grade media, modular decentralised bioreactors and regulatory speed. Europe leads on science and strains; India is racing on policy, manufacturing and cost — and precision-fermentation players now target parity within the decade.
Short, illustrated, sourced guides to agri-food biomanufacturing — written so anyone can follow, and guided by Cortex. New explainers added over time.
A deep dive into biomass fermentation — the branch of smart protein that grows whole microbes as food. Where it stands in 2025–26, why scale-up, not the science, is the bottleneck, and the frontier ideas turning CO₂, methane and crop stubble into protein.
India’s residue-to-protein circle leaks at six points. An interactive map of where value spills — what’s moved since the 2025 baseline, who’s sealing each gap, and what the five years to 2031 could close.
Open the interactive →Why Europe and India are solving the same problem from opposite ends — Europe racing to grow its own protein, India burning residue it could turn into value. With sourced comparison charts.
Read the explainer (PDF) →The same protein your body already loves — grown a smarter way. What they are, how they differ from normal proteins, why they’re named “smart,” and why they matter now. No lab coat required.
Read the explainer (PDF) →The whole field on a single page: where 2025 capital went by route, what has cleared regulation in the EU and India, and how India and Europe divide the problem. Every figure dated and cited.
India has decisively solved the problem it set out to solve in 1965: calorie sufficiency. Foodgrain output hit a record 357.73 million tonnes in 2024–25 and the state distributes free grain to 81.35 crore people. The binding constraint has moved — from production to value, nutrition, and resilience. This paper examines what the government initiated, why, for whom, and where the sector is heading over the next five years.
The Agri-Cortex synthesizes publicly available data from industry bodies (GFI, GFI India, GFI Europe), market-research firms, and government and regulatory sources (DBT / BioE3, EFSA), alongside company reporting. Figures are indicative, dated, and cited inline; definitions differ across sources, so cross-market comparisons are directional rather than like-for-like. Independent analysis, compiled from public sources. Not investment advice.
For questions about this market-intelligence initiative — or to share a perspective on where agri-food biomanufacturing is heading — you're welcome to reach out.
Sourced, dated intelligence on the India × Europe smart-protein economy — new briefings, tracker updates and the occasional field guide. No noise.